The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens. In 2023, Civica struck a deal to produce insulin for the state of California ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new geographies.

Despite recent legislation capping insulin prices and manufacturer assistance programs, some people with diabetes who require insulin still encounter barriers to obtaining a reliable supply.

Last year, Eli Lilly, Novo Nordisk and Sanofi dropped their insulin prices between 65% to 80%. Industry experts attribute the drop to a Medicaid rule change linking drug prices to inflation, meaning ...

Lilly was the first and still only company to cap what people pay at $35 per month for all of our insulins, we cut insulin prices by 70%, and the average monthly out-of-pocket cost for Lilly insul ...

It has filed a lawsuit that accuses the drugmakers and pharmacy benefit managers Express Scripts, Caremark and OptumRx of conspiring to manipulate and inflate insulin prices in the state ...

The 'big three' insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products.

South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.